Literature DB >> 10565891

Development of a universal intimin antiserum and PCR primers.

M Batchelor1, S Knutton, A Caprioli, V Huter, M Zanial, G Dougan, G Frankel.   

Abstract

Enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) constitute a significant risk to human health worldwide. A hallmark of both pathogens is their ability to produce characteristic attaching-and-effacing (A/E) lesions in intestinal epithelial cells. Genes encoding A/E lesion formation map to a chromosomal pathogenicity island termed the locus of enterocyte effacement (LEE). Intimin, an LEE-encoded bacterial adhesion molecule, mediates the intimate bacterium-host cell interaction characteristic of A/E lesions. On the basis of characterization of the C-terminal 280-amino-acid cell binding domain of intimin (Int280(661-939)), four distinct Int280 types (types alpha, beta, gamma, and delta) have been identified. Importantly, Int280alpha and Int280beta antisera specifically recognized their respective intimin types. Using a conserved region of the intimin molecule (Int(388-667)) and primers synthesized to generate the recombinant Int(388-667), we have now generated universal intimin antiserum and PCR primers that are reactive with the different intimin types expressed by both human and animal A/E lesion-forming strains. Use of immunogold electron microscopy to visualize intimin on the surfaces of EPEC and EHEC strains revealed, in general, a uniform distribution on the bacterial cell surface. However, a filamentous staining pattern was observed with a few strains expressing intimin gamma. Cloning of the intimin eae gene from one such strain (strain ICC57) into strain CVD206, an EPEC strain which harbors a null deletion in eae, produced a uniform intimin staining pattern indicating that, if the filamentous staining pattern defines a filamentous form of intimin gamma, it is dependent upon the genetic background of the strain and is not a feature of the intimin molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565891      PMCID: PMC85821          DOI: 10.1128/JCM.37.12.3822-3827.1999

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells.

Authors:  B Kenny; L C Lai; B B Finlay; M S Donnenberg
Journal:  Mol Microbiol       Date:  1996-04       Impact factor: 3.501

2.  Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.

Authors:  B Kenny; R DeVinney; M Stein; D J Reinscheid; E A Frey; B B Finlay
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

3.  A third secreted protein that is encoded by the enteropathogenic Escherichia coli pathogenicity island is required for transduction of signals and for attaching and effacing activities in host cells.

Authors:  L C Lai; L A Wainwright; K D Stone; M S Donnenberg
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion.

Authors:  S Knutton; J Adu-Bobie; C Bain; A D Phillips; G Dougan; G Frankel
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

Review 5.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

6.  A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens.

Authors:  T K McDaniel; K G Jarvis; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

7.  Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation.

Authors:  K G Jarvis; J A Girón; A E Jerse; T K McDaniel; M S Donnenberg; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic Escherichia coli, Citrobacter freundii, and Hafnia alvei.

Authors:  G Frankel; D C Candy; P Everest; G Dougan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Role of intimin and bundle-forming pili in enteropathogenic Escherichia coli adhesion to pediatric intestinal tissue in vitro.

Authors:  S Hicks; G Frankel; J B Kaper; G Dougan; A D Phillips
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

10.  Detection of intimins alpha, beta, gamma, and delta, four intimin derivatives expressed by attaching and effacing microbial pathogens.

Authors:  J Adu-Bobie; G Frankel; C Bain; A G Goncalves; L R Trabulsi; G Douce; S Knutton; G Dougan
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

View more
  14 in total

1.  Enteroaggregative Escherichia coli strains among classical enteropathogenic Escherichia coli O serogroups.

Authors:  Waldir P Elias; Samar F Barros; Cristiano G Moreira; Luiz R Trabulsi; Tânia A T Gomes
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

2.  Intimin types determined by heteroduplex mobility assay of intimin gene (eae)-positive Escherichia coli strains.

Authors:  Kenitiro Ito; Mariko Iida; Mitsugu Yamazaki; Kazuo Moriya; Sanae Moroishi; Jun Yatsuyanagi; Takayuki Kurazono; Noriaki Hiruta; Orn-Anong Ratchtrachenchai
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

3.  Intimin type influences the site of human intestinal mucosal colonisation by enterohaemorrhagic Escherichia coli O157:H7.

Authors:  R J Fitzhenry; D J Pickard; E L Hartland; S Reece; G Dougan; A D Phillips; G Frankel
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

4.  Expression of intimin gamma from enterohemorrhagic Escherichia coli in Citrobacter rodentium.

Authors:  E L Hartland; V Huter; L M Higgins; N S Goncalves; G Dougan; A D Phillips; T T MacDonald; G Frankel
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

5.  Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium.

Authors:  M Ghaem-Maghami; C P Simmons; S Daniell; M Pizza; D Lewis; G Frankel; G Dougan
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Immunological characterization of Escherichia coli O157:H7 intimin gamma1.

Authors:  W-G Son; T A Graham; V P J Gannon
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

7.  Tissue tropism of enteropathogenic Escherichia coli strains belonging to the O55 serogroup.

Authors:  R J Fitzhenry; S Reece; L R Trabulsi; R Heuschkel; S Murch; M Thomson; G Frankel; A D Phillips
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  CesD2 of enteropathogenic Escherichia coli is a second chaperone for the type III secretion translocator protein EspD.

Authors:  Bianca C Neves; Rosanna Mundy; Liljana Petrovska; Gordon Dougan; Stuart Knutton; Gad Frankel
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

9.  Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection.

Authors:  Rosanna Mundy; Liljana Petrovska; Katherine Smollett; Nandi Simpson; Rebecca K Wilson; Jun Yu; Xuanlin Tu; Ilan Rosenshine; Simon Clare; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Characterization of Shiga toxin-producing Escherichia coli (STEC) in feces of healthy and diarrheic calves in Urmia region, Iran.

Authors:  Saei H Dastmalchi; N Ayremlou
Journal:  Iran J Microbiol       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.